Dr Polychronis Pavlidis

Dr Pavlidis is a Consultant Gastroenterologist, Endoscopist and IBD Physician with expertise in providing a holistic and personalised approach for patients with acute and chronic gastrointestinal symptoms or diseases. His subspecialty interests include conditions resulting from the interaction of the gut-brain-microbiome axis, immune-mediated inflammatory bowel diseases, and complications following chemotherapy/immunotherapy/stem cell transplantation for cancer. He is a JAG accredited endoscopist for upper and lower GI diagnostic and therapeutic procedures and contributes to the national bowel cancer screening programme at King's College London Hospital. Following his medical degree (University of Thessaly, Larissa, Greece, 2006) he undertook post-graduate training in London and the south-east of England, working at international centres of excellence including King’s College Hospital and Guy’s and St Thomas’ NHS Foundation Trust. He holds a PhD in Transplantation Immunology and Mucosal Biology from King’s College London (2018) for studying the role of interleukin 22 in inflammatory bowel disease and acute gastrointestinal graft versus host disease. He was the NIHR Academic Clinical Lecturer in Gastroenterology at King’s Health Partners from 2018 to 2021. Polychronis' translational research work aims to deliver stratified medicine approaches in chronic gut inflammation as well as inform evidence-based practice and has been funded by national funding streams (NIHR), charities (CCUK, Guts UK) and other stakeholders. Presentations at national and international fora have received multiple awards while manuscripts have been accepted for publication by high impact journals like Nature Communications, Cell Reports and Gut. Polychronis has co-authored leading national and international guidelines as well as consensus statements on IBD management (BSG 2024), personalised medicine approaches (ECCO 2021) and checkpoint inhibitor induced colitis (BSG 2020). He is an elected member of the BSG IBD Clinical Research Group and contributes to the BSGAR IUS subcommittee’s proceedings.